Skip to content

Study · Not a test of the peptide alone · 2005

1 result

Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone

CATANIA ANNA PIA, LIPTON JAMES M

Journal not recorded21 Sept 2001

PepBankPUB-93553563
Source linkAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, KPV was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking KPV.

  1. 01LabNot a test of KPV aloneOther designActivity measurement

    Peptides carrying the C-terminal alpha-MSH sequence, including alpha-MSH (11-13) (KPV), were the most effective of the antimicrobial peptides tested.

    In plain wordsIn lab tests, peptides with the end sequence of alpha-MSH, including KPV, were the most effective at fighting microbes among those tested.

    Peptide
    KPV
    Outcome
    Not applicableAntimicrobial activity of alpha-MSH-derived sequences
    Study

    n: not reported in source

    Outcome group
    Infection and antimicrobial activity · Infection

    Source sentences

    Summary
    The antimicrobial agent is selected from the group consisting of one or more peptides including the amino acid sequence KPV, one or more peptides including the amino acid sequence MEHFRWG, or a biologically functional equivalent of any of the foregoing.The most effective of the peprides were those b…

    In this study, KPV was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking KPV.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    9 Oct 2026, 18:17 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 02:56 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.